AOCC2024

07:00-08:00 (UTC+8) | Difficult-to-treat inflammatory bowel disease | the definition

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	07:00-08:00	Breakfast with the experts II	Difficult-to-treat inflammatory bowel disease: the definition	Bo Shen	New York-Presbyterian Hospital/Columbia University Irving Medical Center, USA

10:35-12:10 (UTC+8) | Basic Forum I | Innovative approaches in translational markers

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	10:35-11:00	Plenary Lecture	Role of intestinal mucosal barrier in inflammatory bowel disease	Shenghong Zhang	The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
2	11:00-11:25	Plenary Lecture	Gut microbiota and metabolites as predictors of drug response in IBD	Hong Yang	Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
3	11:25-11:50	Plenary Lecture	Non-coding RNAs as emerging biomarkers and therapeutic targets for CD	Xiaowei Liu	Xiangya Hospital, Central South University, Changsha
4	11:50-12:00	Best Abstract V	Macrophage RNF2 facilitates colonic infammation through inhibition of RUNX3/ACSL1 axis-mediated monocyte-macrophage differentiation	Fanyi Meng
5	12:00-12:10	Best Abstract VI	Artificial intelligence-based fingerprint index of visceral adipose tissue for prediction of intestinal damage in patients with Crohn's disease	Qingzhu Zheng

12:10-13:30 (UTC+8) | Luncheon Symposium II | Benefits and safety concerns of novel biologics and small molecules

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	12:10-12:50	Plenary Lecture	Assembling the future through JAK inhibition: creating a better everyday in IBD	Gareth Parkes	Royal London Hospital, UK
2	12:50-13:10	Plenary Lecture	UC histological remission: it is time to take this step now	Russell D. Cohen	University of Chicago Medicine, USA
3	13:10-13:30	Plenary Lecture	Achieve mucosal healing: It's time to initiate biologics earlier	Zhanju Liu	Shanghai Tenth People's Hospital, Tongji University, Shanghai

13:30-16:00 (UTC+8) | Education Forum | The difficulties of fistula in CD

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	13:30-13:50	Plenary Lecture	Shall we raise the concentration of novel biological agents to subdue perianal fistula in Crohn’s disease	Kenji Watanabe	University of Toyama, Toyama
2	13:50-14:10	Plenary Lecture	Effectiveness and safety of IL12/23 and IL23 antibodies in fistula behavior in Crohn’s disease	Ken Takeuchi	Tsujinaka Hospital Kashiwano-Ha, Kashiwa
3	14:10-14:30	Plenary Lecture	Biologic and exploratory drugs for Crohn's-related enterocutaneous fistula in real-world practice	Eun Soo Kim	Kyungpook National University, Daegu
4	14:30-14:50	Plenary Lecture	Optimizing stem cell treatment for complex perianal fistula in CD	Liangru Zhu	Union Hospital, Huazhong University of Science and Technology, Wuhan
5	14:50-15:10	Plenary Lecture	Surgical consideration in the treatment of complex perianal fistula from CD	Weiming Zhu	Jiangsu Province Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing
6	15:10-15:30	Plenary Lecture	Postoperative intestinal fistula: how to avoid, and surgical rescue	Xianrui Wu	The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
7	15:30-16:00	Coffee Break & Poster Viewing

16:00-18:00 (UTC+8) | Clinical Forum I | How to deal with primary loss of response？

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	16:00-16:20	Plenary Lecture	Clinically predicting primary and secondary loss of response - current opinion and future perspectives	Jakob Begun	Mater Research Institute - The University of Queensland, Australia
2	16:20-16:40	Plenary Lecture	Impact of genotype in Immunogenicity and failure to treatment with biologics in IBD	Xiang Gao	The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
3	16:40-17:00	Plenary Lecture	Biologic therapy for inflammatory bowel disease: Real-world effectiveness and impact of drug sequencing after primary loss of response	Bo Shen	New York-Presbyterian Hospital/Columbia University Irving Medical Center, USA
4	17:00-17:20	Plenary Lecture	Small molecule drugs as salvage therapy in moderate-to-severe UC patients without response to biologic agent	Yue Li	Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
5	17:20-17:40	Plenary Lecture	Small molecules beside JAKs: what shall we know currently and in the future?	Jie Liang	Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi’an
6	17:40-18:00	Plenary Lecture	Emerging strategy to initial enhance or re-capture responses for CD patients failing novel biologic agents	Yingde Wang	The First Affiliated Hospital of Dalian Medical University, Dalian

2024-06-15 Saturday